Form 10-Q Valeant Pharmaceuticals For: Sep 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/20/2026

1. SPY
2. META
3. ZION
4. BRZE
5. IBM
6. MMM
7. RAPP
8. IT
9. STLD
10. AMZN

Go back to Form 10-Q Valeant Pharmaceuticals For: Sep 30

Valeant Pharma (VRX) Files Presentation on Philidor; Says No Evidence of Illegal Activity To-Date

October 26, 2015 7:28 AM EDT

Valeant Pharma (NYSE: VRX) filed a presentation related to its conference call on Philidor today. The presentation is embedded below and the following are some highlights from the document:

Says it has no right to remove CEO and management of... More

Valeant Pharma (VRX) Says Philidor Accounting is Appropriate

October 26, 2015 6:16 AM EDT

Valeant Pharma (NYSE: VRX) announced that its Audit and Risk Committee and the full Board of Directors have reviewed the company's accounting for its Philidor arrangement and have confirmed the appropriateness of the company's related revenue recognition and accounting treatment.

Based on its review conducted to date, Valeant also believes that the company is in compliance with applicable law. In light of the recent allegations made regarding Philidor, however, the Board of Directors has decided to establish an ad hoc committee of the board to review allegations related to the company's business relationship... More

Valeant Pharma (VRX) Adds ValueAct's Morfit as Director

October 26, 2015 6:13 AM EDT

Valeant Pharma (NYSE: VRX) announced the addition of G. Mason Morfit, President of ValueAct Capital, to its board of directors effective immediately. Morfit had originally served on the Valeant Board of Directors from May 2007 to May 2014.

"I am pleased to welcome... More